Clinical Trial

A Study on the Preference of Risperidone Dosage Forms

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 24, 2024 (before its estimated February 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.
Trial Details
NCT Number NCT06657430
Lead Sponsor Shanghai Mental Health Center
Conditions Schizophrenia, Bipolar Affective Disorder, Autism Spectrum Disorder, Conduct Disorder, Mental Retardation
Enrollment 1,000 participants
Start Date 2024-09-19
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-10-24